Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Novo Nordisk's Amended Acquisition Proposal
Published 6 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s amended proposal to acquire Metsera, the State of Texas’ attempt to block Kenvue’s planned dividend payment, and how data and AI are transforming pharma’s next frontier in commercial customer engagement.